SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
SEC Accession No. 0001493152-22-011214
Filing Date
2022-04-26
Accepted
2022-04-26 16:06:30
Documents
15

Document Format Files

Seq Description Document Type Size
1 formf-1a.htm F-1/A 2614475
2 ex23-1.htm EX-23.1 6973
3 formdrs_001.jpg GRAPHIC 6805
4 formdrs_012.jpg GRAPHIC 53780
5 formdrs_014.jpg GRAPHIC 54422
6 formdrs_002.jpg GRAPHIC 54422
7 formdrs_003.jpg GRAPHIC 11468
8 formdrs_005.jpg GRAPHIC 18507
9 formdrs_007.jpg GRAPHIC 13811
10 chart_ogd.jpg GRAPHIC 25633
11 formdrs_008.jpg GRAPHIC 12952
12 formdrs_009.jpg GRAPHIC 15165
13 image_004.jpg GRAPHIC 22461
14 ex23-1_001.jpg GRAPHIC 2024
15 ex23-1_002.jpg GRAPHIC 1649
  Complete submission text file 0001493152-22-011214.txt   3027410
Mailing Address 55 PARK LANE LONDON X0 W1K 1NA
Business Address 55 PARK LANE LONDON X0 W1K 1NA 44 (0) 207 495 2379
OKYO Pharma Ltd (Filer) CIK: 0001849296 (see all company filings)

IRS No.: 000000000
Type: F-1/A | Act: 33 | File No.: 333-263326 | Film No.: 22854346
SIC: 2836 Biological Products, (No Diagnostic Substances)